The serum follistatin level is increased in patients with NAFLD and type 2 diabetes [207,208], while individuals with reduced body weight after bariatric surgery exhibited a decrease in serum follistatin level, in conjunction with improved insulin sensitivity and glycemic control [68,209]. This evidence concerns the gene INS and type 2 diabetes mellitus.